GTN

📍 London, United Kingdom🗓 Founded 2017👥 13 employees💰 Last funded Feb 2018

GTN - Transforming drug discovery through interdisciplinary innovation. Bringing a single new drug to the market costs $2.9bn and takes 15 years, with a high chance of failure and often delivering an intervention that barely differs from those already in the market. Projections into the future are not promising, with an expected 50% drop in R&D output every nine years. At GTN, a multidisciplinary, innovation-driven company, we are searching the astronomically large space of drug-like molecules with our unique patented technology, Generative Tensorial Networks. Our software combines and builds upon techniques from machine learning and quantum physics to simulate, filter and search for molecules, discovering molecules entirely hidden from view. This will create substantial efficiencies in the whole drug development cycle.

Total investors

Early stage

Mid stage

Late stage

2017

Founded